Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Epidemiologists | 3 | 2021 | 75 | 1.24 | Why? |
| Sofosbuvir | 2 | 2018 | 518 | 0.62 | Why? |
| Poland | 6 | 2021 | 2368 | 0.61 | Why? |
| Hepacivirus | 2 | 2018 | 1509 | 0.44 | Why? |
| Interferon-alpha | 1 | 2018 | 1442 | 0.39 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.36 | Why? |
| Antiviral Agents | 6 | 2021 | 41703 | 0.28 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.25 | Why? |
| Hepatitis C | 2 | 2021 | 1514 | 0.17 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.16 | Why? |
| Fluorenes | 1 | 2017 | 101 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.15 | Why? |
| Benzimidazoles | 1 | 2017 | 275 | 0.14 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.11 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.11 | Why? |
| Ribavirin | 1 | 2017 | 1182 | 0.10 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.09 | Why? |
| Monitoring, Physiologic | 1 | 2020 | 1956 | 0.09 | Why? |
| Immunoglobulins, Intravenous | 1 | 2020 | 2705 | 0.09 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
| Echocardiography | 1 | 2020 | 3661 | 0.08 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Humans | 11 | 2021 | 930598 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.04 | Why? |
| Adult | 5 | 2021 | 244371 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.03 | Why? |
| Male | 5 | 2021 | 367725 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Female | 5 | 2021 | 380317 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Aged | 4 | 2020 | 215776 | 0.02 | Why? |
| Safety | 1 | 2017 | 1583 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.01 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
Zarebska-Michaluk's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(58)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(60)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_